PubRank

J Viby-Mogensen

Author PubWeight™ 66.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007 2.77
2 A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997 2.35
3 Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997 1.88
4 Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth 1989 1.54
5 Identification of human plasma cholinesterase variants using molecular biological techniques. Acta Anaesthesiol Scand 1995 1.47
6 Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade? Anesthesiology 1990 1.44
7 Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity. Acta Anaesthesiol Scand 1995 1.39
8 Half-life of plasma cholinesterase. Acta Anaesthesiol Scand 1988 1.25
9 Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985 1.14
10 Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase. Anesthesiology 1981 1.09
11 Implementation of pharmaceutical practice guidelines. Anesthesiology 1997 1.08
12 Post-operative recovery after laparoscopic cholecystectomy. Acta Anaesthesiol Scand 2007 1.07
13 Clinical assessment of neuromuscular transmission. Br J Anaesth 1982 1.06
14 Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology 1989 0.99
15 Scandinavian research in anaesthesiology 1981-2000: visibility and impact in EU and world context. Acta Anaesthesiol Scand 2004 0.99
16 Relationship between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthesiol Scand 1987 0.98
17 Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology 1981 0.98
18 The undesirable effects of neuromuscular blocking drugs. Anaesthesia 2009 0.96
19 Bradycardia and cardiac asystole following a single injection of suxamethonium. Acta Anaesthesiol Scand 1984 0.95
20 Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000 0.94
21 Residual curarization in the recovery room. Anesthesiology 1979 0.93
22 Prolonged apnoea after suxamethonium: an analysis of the first 225 cases reported to the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand 1978 0.92
23 Anaesthetic practice and postoperative pulmonary complications. Acta Anaesthesiol Scand 1992 0.92
24 Remifentanil vs. alfentanil for direct laryngoscopy: a randomized study comparing two total intravenous anaesthesia techniques. TIVA for direct laryngoscopy. Acta Anaesthesiol Belg 2002 0.91
25 Twitch tension and train-of-four ratio during prolonged neuromuscular monitoring at different peripheral temperatures. Acta Anaesthesiol Scand 1991 0.90
26 Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 1992 0.89
27 Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand 1998 0.88
28 Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis. Acta Anaesthesiol Scand 1995 0.88
29 The Accelograph: a new neuromuscular transmission monitor. Acta Anaesthesiol Scand 1988 0.87
30 Prolonged residual paralysis after a single intubating dose of rocuronium. Br J Anaesth 2007 0.87
31 Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand 2002 0.87
32 Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. Anesthesiology 1980 0.87
33 Evaluation of intense neuromuscular blockade caused by vecuronium using posttetanic count (PTC). Anesthesiology 1987 0.87
34 Tactile evaluation of the posttetanic count (PTC). Anesthesiology 1984 0.86
35 Relationship of post-tetanic count and train-of-four response during intense neuromuscular blockade caused by atracurium. Br J Anaesth 1987 0.86
36 A double-blind group comparative study using the new anti-depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery. Acta Psychiatr Scand 1985 0.85
37 Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase. Br J Clin Pharmacol 1998 0.85
38 The pharmacodynamics and pharmacokinetics of mivacurium in children. Acta Anaesthesiol Scand 2002 0.84
39 The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients. Acta Anaesthesiol Scand 1990 0.84
40 Risk factors, complications and outcome in anaesthesia. A pilot study. Eur J Anaesthesiol 1986 0.83
41 Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993 0.83
42 Acceleromyography of the orbicularis oculi muscle II: comparing the orbicularis oculi and adductor pollicis muscles. Acta Anaesthesiol Scand 2002 0.83
43 Remifentanil vs. alfentanil infusion in non-paralysed patients: a randomized, double-blind study. Eur J Anaesthesiol 2004 0.82
44 Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase. Acta Anaesthesiol Scand 1993 0.82
45 Serum cholinesterase activity in burned patients. I: biochemical findings. Acta Anaesthesiol Scand 1975 0.81
46 Monitoring of the neuromuscular transmission by electromyography (I). Stability and temperature dependence of evoked EMG response compared to mechanical twitch recordings in the cat. Acta Anaesthesiol Scand 1992 0.81
47 Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand 1995 0.80
48 Arm-to-arm variation when evaluating neuromuscular block: an analysis of the precision and the bias and agreement between arms when using mechanomyography or acceleromyography. Br J Anaesth 2010 0.80
49 [Testing of neuromuscular function during anaesthesia (author's transl)]. Anesth Analg (Paris) 1980 0.80
50 Use of post-tetanic count in assessment of a repetitive vecuronium-induced neuromuscular block. Br J Anaesth 1990 0.80
51 Precurarization--a hazard to the patient? Acta Anaesthesiol Scand 1984 0.79
52 Cholinesterase and succinylcholine. Dan Med Bull 1983 0.79
53 Can rocuronium replace succinylcholine in a rapid-sequence induction of anaesthesia? Acta Anaesthesiol Scand 1999 0.79
54 Rapid simultaneous genotyping of the frequent butyrylcholinesterase variants Asp70Gly and Ala539Thr with fluorescent hybridization probes. Scand J Clin Lab Invest 2002 0.79
55 The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Acta Anaesthesiol Scand 1990 0.79
56 Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA). Acta Anaesthesiol Scand 2003 0.79
57 Comparison of the cardiovascular effects of cisatracurium and vecuronium in patients with coronary artery disease. Can J Anaesth 1998 0.79
58 The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium. Anesthesiology 2000 0.78
59 Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. Anesthesiology 1995 0.78
60 A new nerve stimulator (Myotest). Br J Anaesth 1980 0.78
61 Pretreatment with non-depolarizing muscle relaxants: the influence on neuromuscular transmission and pulmonary function. Acta Anaesthesiol Scand 1980 0.77
62 Succinylcholine neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Anesthesiology 1981 0.77
63 The effect of peripheral hypothermia on a vecuronium-induced neuromuscular block. Acta Anaesthesiol Scand 1991 0.77
64 [Research in Danish departments of anesthesiology at the turn of the century. A bibliometric analysis]. Ugeskr Laeger 2001 0.77
65 The inhibition of serum cholinesterase by urea. Mechanism of action and application in the typing of abnormal genes. Br J Anaesth 1977 0.76
66 Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients. Acta Anaesthesiol Scand 2002 0.76
67 Acceleromyography and mechanomyography for establishing potency of neuromuscular blocking agents: a randomized-controlled trial. Acta Anaesthesiol Scand 2009 0.76
68 Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function. Acta Anaesthesiol Scand 1985 0.75
69 Remifentanil. Anaesthesia 1998 0.75
70 Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing. Anesthesiology 2001 0.75
71 Research output in anaesthesia. Anaesthesia 2003 0.75
72 Central anticholinergic syndrome or postoperative residual block? Eur J Anaesthesiol 2000 0.75
73 Genes and outcome from anaesthesia. Br J Anaesth 2003 0.75
74 Rapid sequence intubation - how? Acta Anaesthesiol Scand 2007 0.75
75 Recovery from neuromuscular blockade and routine monitoring of neuromuscular function. Anaesthesia 2007 0.75
76 Neuromuscular monitoring and postoperative residual curarization. Br J Anaesth 2007 0.75
77 Plasma cholinesterase activity and duration of action of mivacurium in phenotypically normal patients. Acta Anaesthesiol Scand 2002 0.75
78 Mivacurium block in patients with abnormal plasma cholinesterase. Acta Anaesthesiol Scand 1995 0.75
79 Monitoring of neuromuscular transmission by electromyography (II). Evoked compound EMG area, amplitude and duration compared to mechanical twitch recording during onset and recovery of pancuronium-induced blockade in the cat. Acta Anaesthesiol Scand 1993 0.75
80 Clinical use of peripheral nerve stimulators. Acta Anaesthesiol Belg 1988 0.75
81 Mortality among anesthesiologists in Denmark, 1973-95. Acta Anaesthesiol Scand 2002 0.75
82 Thiopental-nitrous oxide- halothane anesthesia and repeated succinylcholine: comparison of preoperative glycopyrrolate and atropine administration. Anesth Analg 1980 0.75
83 Reversal of intense neuromuscular blockade following infusion of atracurium. Anesthesiology 1990 0.75
84 Atracurium (tracrium). Middle East J Anaesthesiol 1988 0.75
85 Dose-response curves for vecuronium during halothane and neurolept anaesthesia: single bolus versus cumulative method. Acta Anaesthesiol Scand 1985 0.75
86 Reaction to succinylcholine in two patients segregating for the plasma cholinesterase allele Ek. Acta Anaesthesiol Scand 1992 0.75
87 Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium. Acta Anaesthesiol Scand 1985 0.75
88 [Bedside monitoring of neuromuscular transmission only with a nerve stimulator]. Masui 1987 0.75
89 Halothane anaesthesia and suxamethonium III. Atropine 30 s before a second dose of suxamethonium during inhalation anaesthesia: effects and side-effects. Acta Anaesthesiol Scand Suppl 1978 0.75
90 Increased sensitivity to succinylcholine in a patient heterozygous for the silent and the fluoride-resistant gene. Anesth Analg 1978 0.75
91 Effect of vecuronium and pancuronium on cardiac performance and transmural myocardial perfusion during ketamine anaesthesia. Acta Anaesthesiol Scand 1984 0.75
92 Serum cholinesterase activity in burned patients. II: anaesthesia, suxamethonium and hyperkalaemia. Acta Anaesthesiol Scand 1975 0.75
93 Timing of tracheal intubation: monitoring the orbicularis oculi, the adductor pollicis or use a stopwatch? Eur J Anaesthesiol 1996 0.75
94 On ORG NC 45 and halothane anaesthesia. Preliminary results. Br J Anaesth 1980 0.75
95 Plasma cholinesterase and malignant hyperthermia. Br J Anaesth 1981 0.75
96 Halothane anaesthesia and suxamethonium I: the significance of preoperative atropine administration. A double-blind study. Acta Anaesthesiol Scand 1976 0.75
97 Thiopentone-nitrous oxide-halothane anaesthesia and suxamethonium: pretreatment with pancuronium and gallamine. Br J Anaesth 1980 0.75
98 Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia. Br J Anaesth 1984 0.75
99 The Radiometer Prize 1995. Acta Anaesthesiol Scand 1996 0.75
100 Acceleromyography of the orbicularis oculi muscle I: significance of the electrode position. Acta Anaesthesiol Scand 2002 0.75
101 Routine use of atropine in obstetric anaesthesia. Br J Anaesth 1988 0.75
102 Atypical serum cholinesterase eliminated by orthotopic liver transplantation. Anesthesiology 1988 0.75
103 Serum cholinesterase variants in the Danish population. Acta Anaesthesiol Scand 1978 0.75
104 The agreement between adductor pollicis mechanomyogram and first dorsal interosseous electromyogram. A pharmacodynamic study of rocuronium and vecuronium. Acta Anaesthesiol Scand 1994 0.75
105 Halothane anaesthesia ans suxamethonium II. The significance of preoperative gallamine administration. Acta Anaesthesiol Scand 1977 0.75
106 Cardiac effects of atropine and gallamine in patients receiving suxamethonium. Br J Anaesth 1980 0.75
107 Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthesiol Scand 1995 0.75
108 Clinical recovery and train-of-four ratio measured mechanically and electromyographically following atracurium. Anesthesiology 1989 0.75
109 A new infusion design for atracurium and vecuronium. Eur J Anaesthesiol 1987 0.75
110 A Danish cholinesterase research unit. Acta Anaesthesiol Scand 1977 0.75
111 Guidelines for anaesthesia care in the Nordic countries. Acta Anaesthesiol Scand 1992 0.75
112 Adverse reactions and interactions of the neuromuscular blocking drugs. Med Toxicol Adverse Drug Exp 1989 0.75
113 The influence of fentanyl on the cardiovascular effect of suxamethonium. Acta Anaesthesiol Scand 1986 0.75
114 Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia. Br J Anaesth 1983 0.75
115 Pseudocholinesterase levels in pregnancy. Anesth Analg 1983 0.75
116 [New stimulation pattern for manual evaluation of neuromuscular transmission--double burst stimulation (DBS)]. Masui 1988 0.75
117 Variations in serum potassium and serum cholinesterase activity after induction with Althesin-suxamethonium and thiopentone-suxamethonium. Acta Anaesthesiol Scand 1974 0.75
118 Cardiac effects of vecuronium and pancuronium during halothane anaesthesia. Br J Anaesth 1983 0.75
119 Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene. Acta Anaesthesiol Scand 1991 0.75